April 21 (Reuters) - Amgen Inc reported higher first-quarter earnings on Tuesday, driven by price increases for its biggest-selling drugs, as well as lower spending on research and development.
The Thousand Oaks, California, drugmaker posted a quarterly net profit of $1.62 billion, or $2.11 per share, a 51 percent increase from $1.07 billion, or $1.40 per share, a year earlier.
Also read: Mining Companies Are Back in the Black
07:15 Telefonica to sell up to 40 percent of Telxius to KKR for 1.3 billion euros11
14:29 Unilever rejects $143 billion Kraft Heinz bid as without merit19
12:33 Kraft Heinz to pursue merger despite Unilever rejection19
18:46 Verizon Slashes Price of Yahoo Deal by at Least $250 Million: Bloomberg20